Using lung ultrasound to improve outcomes in cardiac surgery patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study aims to evaluate the effectiveness of lung ultrasound in identifying early postoperative pulmonary complications in patients undergoing cardiac surgery with cardiopulmonary bypass. Participants will receive lung ultrasound examinations on postoperative days 1 and 3, and the results will be compared to traditional imaging methods like X-rays and CT scans. The study seeks to determine if ultrasound can provide more accurate and timely detection of interstitial pulmonary edema, potentially influencing mid-term patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* open heart surgery with cardiopulmonary bypass (CPB) between 15 December 2023 and 15 December 2024
* signed informed consent for participation in the study

Exclusion Criteria:

* reoperations on the open heart with CPB
* surgical procedures on lungs and lung cancer in the anamnesis
* chronic obstructive pulmonary disease, stage III
* chronic kidney disease, stages 4 and 5
* patients with low Risk Score profile by the Society of Thoracic Surgeons

Where it's running

• Saint Petersburg State University Clinic
  Saint Petersburg, Sankt-Peterburg, Russia Recruiting

Study contacts

• Study coordinator: Aleksei A Filippov, MD, PhD
• Email: aleksei.filippov.chb@gmail.com
• Phone: +79819553639

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Outpatient Cardiac Telerehabilitation for Ischemic Heart Disease

  This study tests whether an outpatient cardiac telerehabilitation program can be as safe and effective as conventional rehab for people with ischemic heart disease.

  Recruiting Lithuanian University of Health Sciences · Kulautuva · NCT07927829

• See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease

  In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.

  Recruiting at 2 sites Phase 4 Odense University Hospital · Copenhagen and 1 other locations · NCT07795398

• Lipid and mitochondrial clues in aortic aneurysm with bicuspid or tricuspid valves

  This study tests whether inflammatory and metabolic signatures in myeloid cells and aortic tissue differ between patients with bicuspid versus tricuspid aortic valves who need surgery for ascending aortic aneurysm.

  Recruiting Centre Hospitalier Universitaire Dijon · Dijon · NCT07695545

• QFR-guided virtual stenting to optimize PCI before the procedure

  We’re testing whether using QFR-based virtual stenting before PCI can improve heart-procedure outcomes compared with standard angiography planning in adults with coronary artery disease.

  Recruiting China National Center for Cardiovascular Diseases · Beijing, Beijing Municipality · NCT07635407

• J-VALVE versus surgical aortic valve replacement for severe aortic regurgitation

  This study will test whether the J‑VALVE transfemoral valve works as well and is as safe as surgical aortic valve replacement in people aged 65 and older with severe native aortic regurgitation.

  Recruiting at 2 sites Second Affiliated Hospital, Zhejiang University, School of Medicine · Hefei, Anhui and 27 other locations · NCT07453407

• LONG NAGOMI PMCF: follow-up of the Ultimaster Nagomi stent in long coronary artery lesions

  This project tests the Ultimaster Nagomi drug-eluting stent in adults undergoing PCI for long coronary lesions to collect real-world safety and effectiveness data.

  Recruiting at 10 sites Fundación EPIC · Cabueñes and 9 other locations · NCT07399002

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.